New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 1, 2013
10:01 EDTARP, ZTS, SSH, PTEN, NOV, HP, SFLY, OIS, NBR, EW, SPN, PDS, OII, NCS, NILEOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Blue Nile (NILE) initiated with an Outperform at Wells Fargo... Edwards Lifesciences (EW) initiated with a Buy at Janney Capital... Helmerich & Payne (HP) initiated with a Neutral at Credit Suisse... NCI Building Systems (NCS) initiated with a Buy at BB&T... Nabors Industries (NBR) initiated with an Underperform at Credit Suisse... National Oilwell (NOV) initiated with a Neutral at Credit Suisse... Oceaneering (OII) initiated with a Neutral at Credit Suisse... Oil States (OIS) initiated with an Outperform at Credit Suisse... Patterson-UTI Energy (PTEN) initiated with a Neutral at Credit Suisse... Precision Drilling (PDS) initiated with a Neutral at Credit Suisse... Shutterfly (SFLY) initiated with a Market Perform at Wells Fargo... Sunshine Heart (SSH) initiated with an Overweight at Piper Jaffray... Zoetis (ZTS) initiated with a Buy at ISI Group... Superior Energy (SPN) initiated with an Outperform at Credit Suisse... Atlas Resource Partners (ARP) initiated with a Neutral at Citigroup.
News For NILE;EW;HP;NCS;NBR;NOV;OII;OIS;PTEN;PDS;SFLY;SSH;SPN;ZTS;ARP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 26, 2015
07:22 EDTPTEN, PTENPatterson-UTI downgraded to Underperform from Outperform at CLSA
Subscribe for More Information
07:22 EDTNBR, NBRNabors Industries downgraded to Underperform from Outperform at CLSA
CLSA downgraded Nabors Industries to Underperform from Outperform despite raising its price target to $16 from $13. CLSA's analyst believes the advancement of unconventional drilling has been one of the most disruptive technologies in the sectors' history and will derail cycle normalization near-term. The firm believes the industry will need half as many rigs to keep production flat until attrition right-sizes the industry.
05:36 EDTSSHSunshine Heart announces FDA approval to resume enrollment in COUNTER HF
Sunshine Heart announced that the FDA has approved the resumption of patient enrollment in its COUNTER HF U.S. pivotal study for the C-Pulse Heart Assist System. As such, the company has already begun the process to provide all pivotal study centers with the information required for their Investigational Review Board to approve the continuation of study enrollment.
May 21, 2015
07:37 EDTZTSPfizer replaces AbbVie as top global pharma pick at Jefferies
Subscribe for More Information
07:25 EDTNBR, HPUBS to hold a conference
Subscribe for More Information
07:14 EDTZTSBMO Capital to hold a conference
Subscribe for More Information
May 20, 2015
05:30 EDTEWEdwards Lifesciences announces outcomes for patients treated with SAPIEN 3 valve
Edwards Lifesciences announced that 30-day outcomes for intermediate-risk patients treated transfemorally with the SAPIEN 3 transcatheter aortic valve at centers in Europe and Canada demonstrated very low mortality and stroke rates, and no severe paravalvular leaks. These independently adjudicated data are consistent with the outcomes recently reported in a similar study of 1,000 patients treated at 51 centers in the United States. In the multi-center study of 101 intermediate-risk patients, all-cause mortality was 1 percent. The frequency of other important complications was also low: the disabling stroke rate was 2 percent, major vascular complications were 2 percent and the permanent pacemaker rate was 4 percent. The investigators also noted that the SAPIEN 3 valve had excellent hemodynamic performance, with very low incidence of significant paravalvular regurgitation, as only 2.3 percent of patients had moderate paravalvular leaks and there were no reports of severe leaks.
May 19, 2015
16:53 EDTSFLYGoogle near to launching new web photo service, Bloomberg says
Subscribe for More Information
09:43 EDTZTSFDA proposes rule to collect antimicrobial sales, distribution data by species
Subscribe for More Information
09:21 EDTEWEdwards Lifesciences voluntarily pauses enrollment for Fortis clinical program
Subscribe for More Information
08:48 EDTEWEdwards Lifesciences reports positive results from treatment with SAPIEN 3
Subscribe for More Information
07:43 EDTARPAtlas Resource Partners 6.5M share Spot Secondary priced at $7.97
Subscribe for More Information
07:31 EDTPTENUBS to hold a conference
Subscribe for More Information
May 18, 2015
19:12 EDTARPOn The Fly: After Hours Movers
Subscribe for More Information
16:21 EDTARPAtlas Resource Partners to acquire Arkoma assets from Atlas Energy for $35.5M
Subscribe for More Information
16:16 EDTARPAtlas Resource Partners files to sell 6.5M shares for limited partners interests
Wells Fargo Securities, Citigroup, Deutsche Bank Securities, J.P. Morgan and Morgan Stanley are acting as joint book-running managers for this offering.
09:06 EDTSFLYMarathon Partners comments on Shutterfly compensation plan
Subscribe for More Information
May 15, 2015
17:03 EDTZTSPershing Square gives quarterly update on stakes
Subscribe for More Information
16:32 EDTNOVBerkshire Hathaway gives quarterly update on stakes
NEW STAKES: None. INCREASED STAKES: IBM (IBM), Precision Castparts (PCP), Wells Fargo (WFC), Phillips 66 (PSX), and US Bancorp (USB). DECREASED STAKES: National Oilwell Varco (NOV), Viacom (VIAB), Bank of New York Mellon (BK), MasterCard (MA), and Visa (V). LIQUIDATED STAKES: None.
07:09 EDTHPHayman Capital gives quarterly update on stakes
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use